QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.104.079533v1 313/2/668    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Snipes, J. A. Articles by Busija, D. W. Search for Related Content PubMed PubMed Citation Articles by Snipes, J. A. Articles by Busija, D. W.

INFLAMMATION AND IMMUNOPHARMACOLOGY

Cloning and Characterization of Cyclooxygenase-1b (Putative Cyclooxygenase-3) in Rat

Departments of Physiology and Pharmacology (J.A.S., B.K., D.W.B.) and Pathology (G.S.S.), Wake Forest University Health Sciences, Winston-Salem, North Carolina; and Department of Neuroscience (J.A.H.), University of Connecticut Health Center, Farmington, Connecticut

A splice variant of cyclooxygenase-1 (COX-1), COX-1b (previously termed as COX-3), has been identified in canine tissues as an acetaminophen-sensitive isoform, but the sequence of COX-1b mRNA and the encoded protein are not known in rats. We cloned and sequenced rat COX-1b mRNA from cerebral endothelial cells. Sequence analysis indicated that the 98-base pair intron-1 of COX-1 gene remains unprocessed in the COX-1b mRNA, causing a frameshift mutation and a 127-amino acid open reading frame with no sequence similarity with known cyclooxygenases. Transient and permanent transfection of COS-7 cells with a vector containing the rat COX-1b cDNA resulted in synthesis of a protein of the expected size. We generated an affinity-purified polyclonal antibody against the rat COX-1b protein. Western blot analysis of rat tissues using this antibody demonstrated the likely existence of rat COX-1b protein in vivo with the highest expression in heart, kidney, and neuronal tissues. Our results on both stable and on transiently transfected COS-7 cells suggest that rat COX-1b does not have cyclooxygenase activity and does not have any effect on the inhibition of prostaglandin production by acetaminophen. Because this protein has a completely different amino acid sequence than COX-1 and COX-2 and it does not have cyclooxygenase activity, we suggest a name cyclooxygenase variant protein to distinguish it from the known prostaglandin-synthesizing cyclooxygenase isoforms.

Address correspondence to: Dr. Bela Kis, Department of Physiology and Pharmacology, Wake Forest University Health Sciences, Medical Center Blvd., Winston-Salem, NC 27157. E-mail: bkis{at}wfubmc.edu

This article has been cited by other articles:

				A. Greenhough, H. J.M. Smartt, A. E. Moore, H. R. Roberts, A. C. Williams, C. Paraskeva, and A. Kaidi The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment Carcinogenesis, March 1, 2009; 30(3): 377 - 386. [Abstract] [Full Text] [PDF]

				R. C. Poulsen, P. J. Moughan, and M. C. Kruger Long-Chain Polyunsaturated Fatty Acids and the Regulation of Bone Metabolism Experimental Biology and Medicine, November 1, 2007; 232(10): 1275 - 1288. [Abstract] [Full Text] [PDF]

				J. Bonnefont, L. Daulhac, M. Etienne, E. Chapuy, C. Mallet, L. Ouchchane, C. Deval, J.-P. Courade, M. Ferrara, A. Eschalier, et al. Acetaminophen Recruits Spinal p42/p44 MAPKs and GH/IGF-1 Receptors to Produce Analgesia via the Serotonergic System Mol. Pharmacol., February 1, 2007; 71(2): 407 - 415. [Abstract] [Full Text] [PDF]

				D. L. Simmons, N. V. Chandrasekharan, D. Hu, K. L. Roos, J. Tomsik, B. Kis, J. A. Snipes, and D. W. Busija Comments on "Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties" J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1412 - 1414. [Full Text] [PDF]

				N. Qin, S.-P. Zhang, T. L. Reitz, J. M. Mei, and C. M. Flores Cloning, Expression, and Functional Characterization of Human Cyclooxygenase-1 Splicing Variants: Evidence for Intron 1 Retention J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1298 - 1305. [Abstract] [Full Text] [PDF]

				A. A. Steiner, A. Y. Rudaya, J. R. Robbins, A. S. Dragic, R. Langenbach, and A. A. Romanovsky Expanding the febrigenic role of cyclooxygenase-2 to the previously overlooked responses Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1253 - R1257. [Abstract] [Full Text] [PDF]

				B. Kis, J. A. Snipes, and D. W. Busija Acetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 1 - 7. [Abstract] [Full Text] [PDF]